| scholarly article | Q13442814 |
| P50 | author | Johan Van Der Vlag | Q43142256 |
| P2093 | author name string | Sylviane Muller | |
| Jean-Paul Briand | |||
| Jo H Berden | |||
| Marc Monestier | |||
| Casandra C van Bavel | |||
| Jürgen Dieker | |||
| P2860 | cites work | Phosphorylation of histone H3 Thr-45 is linked to apoptosis | Q34975324 |
| P433 | issue | 2-3 | |
| P921 | main subject | autoantibody | Q785022 |
| P304 | page(s) | 511-516 | |
| P577 | publication date | 2009-09-10 | |
| P1433 | published in | Molecular Immunology | Q6895954 |
| P1476 | title | Apoptosis-associated acetylation on histone H2B is an epitope for lupus autoantibodies | |
| P478 | volume | 47 |
| Q99711139 | A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells |
| Q41673025 | Acetylated Histones in Apoptotic Microparticles Drive the Formation of Neutrophil Extracellular Traps in Active Lupus Nephritis. |
| Q87736149 | Acetylated histones contribute to the immunostimulatory potential of neutrophil extracellular traps in systemic lupus erythematosus |
| Q111911193 | An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19 |
| Q28534916 | An integrated peptide-antigen microarray on plasmonic gold films for sensitive human antibody profiling |
| Q39669606 | Antimodified protein antibody response pattern influences the risk for disease relapse in patients with rheumatoid arthritis tapering disease modifying antirheumatic drugs |
| Q38036709 | Apoptosis and NET formation in the pathogenesis of SLE. |
| Q55113458 | Autoantibodies Recognizing Secondary NEcrotic Cells Promote Neutrophilic Phagocytosis and Identify Patients With Systemic Lupus Erythematosus. |
| Q36174201 | Autoantibodies against Modified Histone Peptides in SLE Patients Are Associated with Disease Activity and Lupus Nephritis. |
| Q56806670 | Autoantibodies in SLE: Specificities, Isotypes and Receptors |
| Q38160040 | Autoantigens: novel forms and presentation to the immune system |
| Q36257320 | Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve? |
| Q36527598 | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus |
| Q37727677 | B Cell Tolerance to Deiminated Histones in BALB/c, C57BL/6, and Autoimmune-Prone Mouse Strains. |
| Q37705429 | Breaking immunological tolerance in systemic lupus erythematosus. |
| Q38926368 | Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis |
| Q38240144 | Clearance of Apoptotic Bodies, NETs, and Biofilm DNA: Implications for Autoimmunity |
| Q91672607 | Clinical Implications of Excessive Neutrophil Extracellular Trap Formation in Renal Autoimmune Diseases |
| Q37751860 | Cracking the death code: apoptosis-related histone modifications |
| Q37778643 | Cutaneous lupus erythematosus: recent lessons from animal models |
| Q28387136 | Does antigen masking by ubiquitin chains protect from the development of autoimmune diseases? |
| Q40365709 | Enhanced activation of dendritic cells by autologous apoptotic microvesicles in MRL/lpr mice |
| Q38152825 | Epigenetic dysregulation in systemic lupus erythematosus |
| Q37785993 | Epigenetic regulation of cell life and death decisions and deregulation in cancer |
| Q37830732 | Epigenetics in lupus |
| Q35620090 | Epigenetics in systemic lupus erythematosus: leading the way for specific therapeutic agents |
| Q34463063 | Epigenetics of autoantigens: new opportunities for therapy of autoimmune diseases |
| Q38380209 | Epigenomics of autoimmune diseases |
| Q33674468 | Identification of autoreactive B cells with labeled nucleosomes |
| Q64110143 | Low Levels of IgM and IgA Recognizing Acetylated C1-Inhibitor Peptides Are Associated with Systemic Lupus Erythematosus in Taiwanese Women |
| Q38099772 | Neutrophil extracellular chromatin traps connect innate immune response to autoimmunity |
| Q50874354 | Nitration of H2B histone elicits an immune response in experimental animals. |
| Q36377207 | On silico peptide microarrays for high-resolution mapping of antibody epitopes and diverse protein-protein interactions. |
| Q55331760 | Potential Involvement of Platelet-Derived Microparticles and Microparticles Forming Immune Complexes during Monocyte Activation in Patients with Systemic Lupus Erythematosus. |
| Q38068181 | Proteins derived from neutrophil extracellular traps may serve as self-antigens and mediate organ damage in autoimmune diseases |
| Q30375585 | Quantitative proteomic analysis of histone modifications |
| Q37828164 | Regulatory and pathogenetic mechanisms of autoantibodies in SLE. |
| Q33911230 | SAHA and S116836, a novel tyrosine kinase inhibitor, synergistically induce apoptosis in imatinib-resistant chronic myelogenous leukemia cells. |
| Q36084984 | Specific post-translational histone modifications of neutrophil extracellular traps as immunogens and potential targets of lupus autoantibodies |
| Q50082915 | Sulforaphane restores acetyl-histone H3 binding to Bcl-2 promoter and prevents apoptosis in ethanol-exposed neural crest cells and mouse embryos |
| Q34849082 | Systemic lupus erythematosus patients contain significantly less igm against mono-methylated lysine than healthy subjects |
| Q38212757 | The clinical significance of posttranslational modification of autoantigens |
| Q38206945 | The pathogenesis and diagnosis of systemic lupus erythematosus: still not resolved |
| Q34422017 | The role of dendritic cells in tissue-specific autoimmunity. |
| Q28389137 | The role of epigenetic mechanisms and processes in autoimmune disorders |
| Q38209945 | The spectrum of anti-chromatin/nucleosome autoantibodies: independent and interdependent biomarkers of disease |
| Q89356195 | Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process |
Search more.